121 related articles for article (PubMed ID: 15225840)
1. 1,25-Dihydroxyvitamin D and three low-calcemic analogs decrease UV-induced DNA damage via the rapid response pathway.
Wong G; Gupta R; Dixon KM; Deo SS; Choong SM; Halliday GM; Bishop JE; Ishizuka S; Norman AW; Posner GH; Mason RS
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):567-70. PubMed ID: 15225840
[TBL] [Abstract][Full Text] [Related]
2. 1α,25 dihydroxyvitamin D3 enhances cellular defences against UV-induced oxidative and other forms of DNA damage in skin.
Gordon-Thomson C; Gupta R; Tongkao-on W; Ryan A; Halliday GM; Mason RS
Photochem Photobiol Sci; 2012 Dec; 11(12):1837-47. PubMed ID: 23069805
[TBL] [Abstract][Full Text] [Related]
3. Skin cancer prevention: a possible role of 1,25dihydroxyvitamin D3 and its analogs.
Dixon KM; Deo SS; Wong G; Slater M; Norman AW; Bishop JE; Posner GH; Ishizuka S; Halliday GM; Reeve VE; Mason RS
J Steroid Biochem Mol Biol; 2005 Oct; 97(1-2):137-43. PubMed ID: 16039116
[TBL] [Abstract][Full Text] [Related]
4. Differential photoprotective effects of 1,25-dihydroxyvitamin D3 and a low calcaemic deltanoid.
Dixon KM; Sequeira VB; Deo SS; Mohan R; Posner GH; Mason RS
Photochem Photobiol Sci; 2012 Dec; 11(12):1825-30. PubMed ID: 22907250
[TBL] [Abstract][Full Text] [Related]
5. In vivo relevance for photoprotection by the vitamin D rapid response pathway.
Dixon KM; Deo SS; Norman AW; Bishop JE; Halliday GM; Reeve VE; Mason RS
J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):451-6. PubMed ID: 17223553
[TBL] [Abstract][Full Text] [Related]
6. 1,25-Dihydroxyvitamin D3 and analogues protect primary human keratinocytes against UVB-induced DNA damage.
De Haes P; Garmyn M; Verstuyf A; De Clercq P; Vandewalle M; Degreef H; Vantieghem K; Bouillon R; Segaert S
J Photochem Photobiol B; 2005 Feb; 78(2):141-8. PubMed ID: 15664501
[TBL] [Abstract][Full Text] [Related]
7. The controversial role of vitamin D in the skin: immunosuppression vs. photoprotection.
Kuritzky LA; Finlay-Jones JJ; Hart PH
Clin Exp Dermatol; 2008 Mar; 33(2):167-70. PubMed ID: 18205854
[TBL] [Abstract][Full Text] [Related]
8. Two 14-epi analogues of 1,25-dihydroxyvitamin D3 protect human keratinocytes against the effects of UVB.
De Haes P; Garmyn M; Verstuyf A; De Clercq P; Vandewalle M; Vantieghem K; Degreef H; Bouillon R; Segaert S
Arch Dermatol Res; 2004 May; 295(12):527-34. PubMed ID: 15042383
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of cyclooxygenase-2 (COX-2) by 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3, a less calcemic vitamin D analog.
Aparna R; Subhashini J; Roy KR; Reddy GS; Robinson M; Uskokovic MR; Venkateswara Reddy G; Reddanna P
J Cell Biochem; 2008 Aug; 104(5):1832-42. PubMed ID: 18348265
[TBL] [Abstract][Full Text] [Related]
10. 1α,25(OH)₂-vitamin D and a nongenomic vitamin D analogue inhibit ultraviolet radiation-induced skin carcinogenesis.
Dixon KM; Norman AW; Sequeira VB; Mohan R; Rybchyn MS; Reeve VE; Halliday GM; Mason RS
Cancer Prev Res (Phila); 2011 Sep; 4(9):1485-94. PubMed ID: 21733837
[TBL] [Abstract][Full Text] [Related]
11. 1 alpha,25-Dihydroxyvitamin D(3) is a preventive factor in the metastasis of lung cancer.
Nakagawa K; Kawaura A; Kato S; Takeda E; Okano T
Carcinogenesis; 2005 Feb; 26(2):429-40. PubMed ID: 15539405
[TBL] [Abstract][Full Text] [Related]
12. Systemic treatments with the low-calcemic 1,25(OH)(2)D(3) analogs JKF or QW increase both the morphological and biochemical responses to estradiol-17beta in rat tibiae.
Somjen D; Katzburg S; Posner GH; Livne E; Kaye AM
J Cell Biochem; 2007 Apr; 100(6):1406-14. PubMed ID: 17163482
[TBL] [Abstract][Full Text] [Related]
13. Superagonistic action of 14-epi-analogs of 1,25-dihydroxyvitamin D explained by vitamin D receptor-coactivator interaction.
Eelen G; Verlinden L; Rochel N; Claessens F; De Clercq P; Vandewalle M; Tocchini-Valentini G; Moras D; Bouillon R; Verstuyf A
Mol Pharmacol; 2005 May; 67(5):1566-73. PubMed ID: 15728261
[TBL] [Abstract][Full Text] [Related]
14. 1α,25-Dihydroxyvitamin D3 reduces several types of UV-induced DNA damage and contributes to photoprotection.
Song EJ; Gordon-Thomson C; Cole L; Stern H; Halliday GM; Damian DL; Reeve VE; Mason RS
J Steroid Biochem Mol Biol; 2013 Jul; 136():131-8. PubMed ID: 23165145
[TBL] [Abstract][Full Text] [Related]
15. Differential biologic effects of CPD and 6-4PP UV-induced DNA damage on the induction of apoptosis and cell-cycle arrest.
Lo HL; Nakajima S; Ma L; Walter B; Yasui A; Ethell DW; Owen LB
BMC Cancer; 2005 Oct; 5():135. PubMed ID: 16236176
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D metabolism.
Lehmann B; Meurer M
Dermatol Ther; 2010; 23(1):2-12. PubMed ID: 20136904
[TBL] [Abstract][Full Text] [Related]
17. [Recent progress of study on vitamin D analogs].
Kittaka A; Saito N; Takano M
Clin Calcium; 2006 Jul; 16(7):1154-65. PubMed ID: 16816476
[TBL] [Abstract][Full Text] [Related]
18. Photoprotection by 1alpha,25-dihydroxyvitamin D and analogs: further studies on mechanisms and implications for UV-damage.
Mason RS; Sequeira VB; Dixon KM; Gordon-Thomson C; Pobre K; Dilley A; Mizwicki MT; Norman AW; Feldman D; Halliday GM; Reeve VE
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):164-8. PubMed ID: 20399269
[TBL] [Abstract][Full Text] [Related]
19. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
20. Low-calcemic, efficacious, 1alpha,25-dihydroxyvitamin D3 analog QW-1624F2-2: calcemic dose-response determination, preclinical genotoxicity testing, and revision of A-ring stereochemistry.
Posner GH; Jeon HB; Sarjeant A; Riccio ES; Doppalapudi RS; Kapetanovic IM; Saha U; Dolan P; Kensler TW
Steroids; 2004; 69(11-12):757-62. PubMed ID: 15579327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
